[1] Ishiwada N, Kitajima H, Morioka I, et al. Nationwide survey of neonatal invasive fungal infection in Japan[J]. Med Mycol, 2018,56(6):679-686. [2] Mantadakis E, Pana ZD, Zaoutis T. Candidemia in children:Epidemiology, prevention and management[J].Mycoses,2018, 61(9):614-622. [3] Pana ZD, Roilides E, Warris A, et al. Epidemiology of invasive fungal disease in dhildren[J]. J Pediatric Infect Dis Soc,2017, 6(Suppl_1):S3-S11. [4] Aliaga S, Clark RH, Laughon M, et al. Decreasing incidence of candidiasis in infants in neonatal intensive care units[J]. Pediatrics,2014,133, 236-242. [5] Ramos JT, Francisco L, Daoud Z. Invasive fungal infections in children:similarities and differences with adults[J]. Rev Esp Quimioter, 2016, 29(Suppl 1):59-65. [6] Kelly MS, Benjamin DK, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants[J]. Clin Perinatol, 2015, 42(1):105-117. [7] Benedict K, Roy M, Kabbani S, et al. Neonatal and pediatric candidemia:results from population-based active laboratory surveillance in four US locations, 2009-2015 external icon[J].Pediatric Infect Dis Soc,2018,7(3):e78-e85. [8] Pemán J, Ruiz-Gaitán A. Candidemia from urinary tract source:the challenge of candiduria[J]. Hosp Pract (1995), 2018, 46(5):243-245. [9] de AraujoMotta F, Dalla-Costa LM, Dominguez Muro M, et al. Risk adjustment for congenital heart surgery score as a risk factor for candidemia in children undergoing congenital heart defect surgery[J]. Pediatr Infect Dis J, 2016, 35(11):1194-1198. [10] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童侵袭性肺部真菌感染诊治指南(2009版)[J].中华儿科杂志, 2009, 47(2):96-97. [11] Yu YF, Du LZ, Yuan TM,etal. Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients[J]. Am J Perinatol,2013, 30(07):589-594. [12] 母发光, 何海兰, 李晶. 儿童侵袭性肺部真菌感染危险因素分析[J]. 中国当代儿科杂志, 2014, 16(8):779-782. [13] 李燕,廖丹,蒙丹华,等. 新生儿侵袭性真菌感染危险因素分析[J]. 中华妇幼临床医学杂志(电子版),2016,12(4):390-394. [14] 孙海燕, 刘飞宇, 张雷,等. 血液病患者侵袭性真菌感染危险评分系统的建立[J]. 中国药房, 2018,29(9):1270-1273. [15] 黄敬孚.侵袭性肺念珠菌病的诊治[J].中华儿科杂志, 2009,47(4):318-319. [16] Guinea J. Global trends in the distribution of Candida species causing candidemia[J]. Clin Microbiol Infect, 2014, 20(Suppl_6):5-10. [17] Zaoutis T. Candidemia in children[J]. Curr Med Res Opin, 2010, 26(7):1761-1768. [18] Chan S, Baley ED, Hossain J, et al. Candida species bloodstream infections in hospitalised children:A 10-year experience[J]. J Paediatr Child Health,2015, 51(9):857-860. [19] Tadec L, Talarmin JP, Gastinne T, et al. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of candidemia at a single French hospital:a 7-year study[J]. Mycoses. 2016,59(5):296-303. [20] Prasad PA, Fisher BT, Coffin SE, et al. Pediatric risk factors for candidemia secondary to Candida glabrata and Candida krusei species[J]. J Pediatric Infect Dis Soc,2013,2(3):263-266. [21] Hsu JF, Lai MY, Lee CW, et al. Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates[J].BMC Infect Dis, 2018, 18(1):194-205. [22] 陈丽, 张伟丽, 叶先飞, 等. 恶性血液病患者医院侵袭性真菌感染的危险因素分析[J]. 中国微生态学杂志, 2015, 27(4):417-420. [23] Hu HJ, Zhang GQ, Zhang Q, et al. Probioticsprevent Candida colonization and invasive fungal sepsis in preterm neonates:a systematic review and meta-analysis of randomized controlled trials[J]. Pediatr Neonatol, 2017, 58(2):103-110. [24] 郝飞, 王莉, 周村建. 糖皮质激素与侵袭性真菌感染[J]. 中国真菌学杂志, 2012, 7(6):367-371. [25] Prasad R, Devaux F, Dhamgaye S, et al. Response of pathogenic and non-pathogenic yeasts to steroids[J]. J Steroid Biochem Mol Biol,2012,129(1-2):61-69. [26] Calley JL, Warris A. Recognition and diagnosis of invasive fungal infections in neonates[J]. J Infect 2017, 74:S108-S113. [27] King J, Pana ZD, Lehrnbecher T, et al. Recognition and clinical presentation of invasive fungal disease in neonates and children[J]. J Pediatric Infect Dis Soc, 2017, 6(Suppl 1):S12-S21. |